`HEALTH`
## Unmasking Hypermobility: The ‘Bendy Disease’ Causing Widespread Pain and Diagnostic Delays
**Hundreds of thousands across the UK may be living with Hypermobility, a connective tissue disorder colloquially known as the ‘bendy disease,’ which manifests as chronic pain and debilitating fatigue. Despite its significant prevalence, many individuals face prolonged delays in receiving an accurate diagnosis, leading to years of suffering and inadequate management.**
Often dismissed as simply being ‘flexible,’ Hypermobility is far more complex than just having unusually mobile joints. It refers to a condition where joints move beyond their normal range due to laxity in the connective tissues – primarily collagen. While some individuals experience benign joint hypermobility with no adverse symptoms, for many, it is a debilitating chronic condition known as Hypermobility Spectrum Disorder (HSD) or, in its more severe forms, Hypermobile Ehlers-Danlos Syndrome (hEDS).
The hallmark symptoms of Hypermobility beyond joint laxity include persistent, often widespread musculoskeletal pain, chronic fatigue that isn’t relieved by rest, and frequent joint dislocations or subluxations. Patients may also experience a range of associated issues, such as digestive problems, autonomic dysfunction (like POTS – postural orthostatic tachycardia syndrome), anxiety, and brittle skin. These symptoms can severely impact daily life, limiting mobility, hindering employment, and affecting mental well-being.
Despite estimates suggesting that hundreds of thousands in the UK are affected, the path to diagnosis is often fraught with difficulty. Many healthcare professionals lack sufficient training and awareness regarding Hypermobility, leading to misdiagnoses or symptoms being attributed to unrelated conditions like fibromyalgia or chronic fatigue syndrome. This diagnostic odyssey can span years, even decades, leaving patients feeling unheard, dismissed, and without appropriate care, often resulting in worsening symptoms and significant psychological distress.
Dr. Anya Sharma, a consultant rheumatologist specializing in connective tissue disorders, emphasizes the critical need for improved medical education. “Hypermobility is not a rare condition, yet it remains significantly under-recognized. We need to equip our healthcare professionals with the knowledge to identify these patients early, prevent long-term complications, and provide targeted support. Early intervention, including physiotherapy, pain management, and lifestyle adjustments, can drastically improve a patient’s quality of life.”
As awareness slowly grows, the hope is that Hypermobility will shed its ‘little-known’ label and gain the recognition it deserves within the medical community and public consciousness. For the hundreds of thousands living with this often-invisible disability, timely diagnosis and effective management are not just desirable – they are essential for a life free from preventable pain and debilitating fatigue.
